$20.090
+0.767 (+3.82%)收盤時
ADRX 同業比較
In the context of the broader market, ADRX competes directly with industry leaders such as HCSG and ICFI. With a market capitalization of $2.05B, it holds a leading position in the sector. When comparing efficiency, ADRX's gross margin of N/A stands against HCSG's 15.89% and ICFI's 34.40%. Such benchmarking helps identify whether ADARx Pharmaceuticals, Inc. is trading at a premium or discount relative to its financial performance.
ADARx Pharmaceuticals, Inc. 財務表現
The company successfully raised $446 million in its IPO, exceeding its initial fundraising goals, which indicates robust market demand for its products.
Financials
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。